Close menu




December 19th, 2025 | 07:00 CET

Milestone for Almonty Industries! Full order books at RENK and TKMS! Here is what analysts say

  • Mining
  • Tungsten
  • Investments
  • Defense
Photo credits: TKMS AG

A milestone for Almonty Industries: the tungsten mine in South Korea goes into operation. This positions the raw material gem for strong revenue and earnings growth in the coming years. Analyst estimates are based on significantly lower prices and could therefore be too conservative. The stock is rebounding. Defense stocks are currently being weighed down by the possibility of peace in Ukraine, but order books remain well filled. Shortly before Christmas, RENK is celebrating a million-euro order from the German Armed Forces for various tanks. TKMS has no worries about revenue for the coming years, with an order backlog of EUR 18.5 billion, nearly nine times its annual sales. Analysts recommend buying.

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: ALMONTY INDUSTRIES INC. | CA0203987072 , RENK AG O.N. | DE000RENK730 , TKMS AG & CO KGAA | DE000TKMS001

Table of contents:


    Almonty Industries: Cash to start rolling in from 2026

    A strong reaction from Almonty shares! After a weak Nasdaq had stifled an 8% jump in the share price on Wednesday, it rose significantly again yesterday. There are currently numerous reasons for Almonty's share price to rise.

    On Monday, the tungsten producer announced that it would withdraw a securities prospectus ("base prospectus") that would have enabled further capital measures and would no longer use it. Following the recent capital increase with gross proceeds of around USD 130 million, the Company is currently fully financed. This was naturally well received by investors.

    Then, on Tuesday evening, came the long-awaited milestone announcement: ore was mined for the first time from the Sangdong tungsten mine in South Korea. This means that commercial production can begin. In the first expansion stage, an annual output of 640,000 tons of tungsten ore is planned. Within a few years, the plan is to expand to 1.2 million tons. For Almonty, this means strong revenue growth and likely fantastic margins from 2026 onwards. The mine was planned at prices of USD 200 to 300 per MTU. Currently, the spot price is closer to USD 800, and CEO Lewis Black recently indicated that a rise to USD 1,000 would come as no surprise. Sangdong will also play an important strategic role. The United States, the EU, and South Korea share the goal of becoming more independent in terms of the critical raw material tungsten. China currently covers more than 80% of global tungsten demand and has shown this year that it is happy to use this as leverage. Starting next year, the Sangdong mine will be essential for a new tungsten supply chain for Western countries, thereby reducing China's potential for blackmail.

    Almonty already operates a tungsten mine in Portugal. This mine generated approximately CAD 9 million in revenue in the third quarter, and the Company plans to expand it further. Analysts at Oppenheimer expect massive growth in the coming years. By 2026, the CAD 100 million revenue mark is expected to be easily surpassed. By 2028, it is expected to exceed CAD 600 million. As already described, it should be noted that the analysts' estimates are based on significantly lower tungsten prices.

    There should be no shortage of price drivers for Almonty shares in the coming year: Sangdong is ramping up, Portugal is being expanded, and the recently acquired tungsten mine in the US is set to go into operation. This would mark the first time in a decade that tungsten has been produced in the US. Currently, the country is 100% dependent on imports.

    https://youtu.be/CDgG7rkTUuY?si=EQRBlxy5BIx9A2Jo

    RENK: Orders at the end of the year

    Defense stocks trended weaker on hopes for peace in the war between Russia and Ukraine. RENK's share price is trading at around EUR 53, well below its annual high of EUR 90 at the beginning of October. Too low, in JPMorgan's view. Analysts recently confirmed their "Overweight" rating. Experts see the fair value at EUR 75.

    At the end of the year, the order book is filling up at RENK, a specialist in drive solutions for the military sector. The Company has received orders to supply transmissions for the Puma infantry fighting vehicle, the Büffel armored recovery vehicle, and the Boxer wheeled armored vehicle, which are intended for the German Armed Forces. The total value of the orders is EUR 45 million. RENK emphasizes that the orders will significantly increase the operational capability of the armed forces.

    "Against the backdrop of new NATO capability requirements and the initiated build-up of forces, we are focusing on reliably meeting our customers' growing demand for vehicle platforms with high-quality drive components," said Michael Masur, CEO Vehicle Mobility Solutions, RENK GmbH. "Our battle-tested drive solutions form the backbone of military mobility and are a key element of European operational capability. We are therefore all the more proud to be making a central contribution to the security and performance of the German Armed Forces."

    TKMS: Strong order backlog

    After its celebrated IPO in October, things quietened down somewhat for TKMS shares. In the first few days of trading, the share price briefly reached the EUR 100 mark. Since then, the share price has fallen back to EUR 64.

    However, the operational outlook for the future is very positive. As part of the publication of the figures for the 2024/2025 financial year, the Company also reported on its order intake, and the results were impressive. TKMS received EUR 8.8 billion in orders, six times as many as in the previous year. As of September 30, 2025, the order backlog stood at around EUR 18.2 billion, a record level. To put this into context, TKMS generated sales of EUR 2.2 billion in the reporting year. Sales growth for the coming years is already practically guaranteed.

    TKMS is aiming for average sales growth of 10% for the coming years, with an upward trend. The Company is targeting an adjusted EBIT margin of 7%.

    Following the publication, Deutsche Bank raised its price target for TKMS shares slightly from EUR 80 to EUR 82. Analysts are particularly optimistic about margin development and believe that the Company may even exceed its targets.


    Almonty is likely to continue its wave of success in the coming year. In view of the revenue and earnings opportunities, and also in comparison to MP Materials, the share currently appears to be anything but expensive. The defense stocks TKMS and RENK are weighed down by the possibility of peace in Ukraine. However, the order books are well filled for the coming years.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Armin Schulz on October 13th, 2026 | 05:26 CEST

    Almonty Industries, Rheinmetall, Lockheed Martin – Tungsten, Defence and a Share Price Decline That Could Open Up Opportunities

    • Almonty Industries
    • Rheinmetall
    • Lockheed Martin
    • Tungsten
    • Tungsten Mine
    • Tungsten Concentrate
    • Sangdong
    • Defence
    • Defence Industry

    Sangdong is producing tungsten again for the first time since 1993. Almonty's South Korean mine is now supplying a raw material from outside China that is urgently needed in defence and is also found in an increasing number of high-tech devices. China's export restrictions have driven up tungsten prices in the West, while demand remains strong. The same is true of defence. On September 14, Rheinmetall booked an order for tens of thousands of artillery shells, while Lockheed Martin announced a framework agreement worth up to USD 1.2 billion for tactical missiles on September 21. Yet the stock market has so far shown little reaction to these developments. All three stocks are under pressure. We therefore take a closer look at Almonty Industries, Rheinmetall and Lockheed Martin.

    Read